Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
5 studies found for:    17135584 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Low Glycemic Index Dietary Intervention Program in Nonalcoholic Fatty Liver Disease
Condition: Nonalcoholic Fatty Liver Disease
Interventions: Other: Low glycemic index dietary intervention program;   Other: simple lifestyle advice
2 Completed Role of Pioglitazone in the Treatment of Non-alcoholic Steatohepatitis (NASH)
Condition: Nonalcoholic Steatohepatitis
Interventions: Drug: Pioglitazone;   Drug: Placebo
3 Completed Trial of Hepaguard® in Adults With Nonalcoholic Steatohepatitis
Condition: Nonalcoholic Fatty Liver Disease
Interventions: Drug: Phyllanthus urinaria;   Drug: Placebo
4 Completed Treatment of Nonalcoholic Fatty Liver Disease With Probiotics and Prebiotics
Condition: Nonalcoholic Fatty Liver Disease
Interventions: Drug: Lepicol probiotic & prebiotic formula;   Other: Simple lifestyle advice
5 Enrolling by invitation Lifestyle Versus Ezetimibe Plus Lifestyle in Patients With Non-alcoholic Steatohepatitis
Condition: •Non-alcoholic Steatohepatitis (NASH)
Interventions: Drug: Ezetimibe;   Behavioral: Lifestyle

Indicates status has not been verified in more than two years